Blood pressure

Healthy Foods Deliver Defense Against Cancer and Heart Disease

Retrieved on: 
Wednesday, February 21, 2024

The vitamins and minerals in "good-for-you" nourishment provide energy for daily living, help the body grow and repair and can prevent diet-related illnesses like cancer and heart disease.

Key Points: 
  • The vitamins and minerals in "good-for-you" nourishment provide energy for daily living, help the body grow and repair and can prevent diet-related illnesses like cancer and heart disease.
  • According to the Centers for Disease Control and Prevention, heart disease is the leading cause of death in the United States, followed by cancer.
  • There are a number of factors that can increase the risk of developing heart disease, including high blood pressure, high cholesterol, obesity and diabetes .
  • Research shows that in addition to inhibiting colon, prostate and breast cancer cell growth, they can also protect against heart disease.

An awkward family reunion: Sea monsters are our cousins

Retrieved on: 
Wednesday, February 21, 2024

KANSAS CITY, Mo., Feb. 21, 2024 /PRNewswire/ -- The sea lamprey, a 500-million-year-old animal with a sharp-toothed suction cup for a mouth, is the thing of nightmares. A new study from the Stowers Institute for Medical Research discovered that the hindbrain—the part of the brain controlling vital functions like blood pressure and heart rate—of both sea lampreys and humans is built using an extraordinarily similar molecular and genetic toolkit.

Key Points: 
  • The team unexpectedly uncovered that a crucial molecular cue is very broadly required during vertebrate hindbrain development.
  • Because most vertebrates, including humans, have jaws, this striking difference in sea lampreys makes them valuable models for understanding the evolution of vertebrate traits.
  • Surprisingly, they found that the sea lamprey core hindbrain circuit is also initiated by retinoic acid, providing evidence that these sea monsters and humans are much more closely related than anticipated.
  • "People thought that because sea lampreys lack a jaw, their hindbrain was not formed like other vertebrates," said Krumlauf.

NIH grants $2.3M to evaluate the impact of ViTrack® on maternal and child health during pregnancy

Retrieved on: 
Tuesday, February 20, 2024

NEW YORK, Feb. 20, 2024 /PRNewswire/ -- Dynocardia, developer of ViTrack, the first-of-its-kind non-invasive, wearable blood pressure (BP) and heart monitor, and NYC Health + Hospitals, the nation's largest safety net health system, are partnering on a study of hypertensive diseases of pregnancy (HDP). The study will include at least 150 women who are pregnant or have recently given birth. The perinatal study addresses a long-standing unmet need for accurate and continuous BP for reliable diagnosis of HDP and for prediction and early detection of preeclampsia. The research is being funded by a $2.3M grant from the National Institute of Health's National Heart, Lung, and Blood Institute (NHLBI).

Key Points: 
  • The research is being funded by a $2.3M grant from the National Institute of Health's National Heart, Lung, and Blood Institute (NHLBI).
  • HDP, a constellation of high BP disorders that may occur during pregnancy, affects both the mother and the child and is a leading cause of pregnancy-related complications and death globally.
  • While the risks posed by HDP have doubled over the past decade in the United States, the effects on the maternal population are not evenly distributed.
  • Moreover, pregnant women are even more vulnerable to these errors due to hemodynamic and vascular changes that occur during pregnancy.

Embrace Heart Health and the Power of Walnuts During American Heart Month

Retrieved on: 
Thursday, February 15, 2024

FOLSOM, Calif., Feb. 15, 2024 /PRNewswire/ -- A new survey1 from California Walnuts just revealed that only one-fifth of Americans (19%) say they eat enough walnuts to support a diet for heart health. With their exceptional nutritional profile, Americans are missing out on a delicious and easy way to support a healthy heart.

Key Points: 
  • Heart disease remains the leading cause of death in the U.S.,2 but research has shown that simple dietary changes can have a significant impact on heart health.
  • In recognition of American Heart Month, California Walnuts encourages Americans to embrace heart health by including walnuts in their daily diet.
  • Over the past three decades, studies have demonstrated the cardiovascular benefits of walnuts, exploring how eating walnuts affects various factors related to heart health such as cholesterol, blood pressure, inflammation and blood vessel function.
  • Visit walnuts.org/american-heart-month for heart-healthy recipe ideas, tips for maintaining freshness and more information about walnuts and heart health.

Marathon Health Ranked No. 1 Employer-Sponsored Healthcare Service

Retrieved on: 
Thursday, February 15, 2024

INDIANAPOLIS, Feb. 15, 2024 /PRNewswire/ -- Marathon Health, a national leader in delivering advanced primary care solutions for employers, today announced its selection as 2024 Best in KLAS in the employer-sponsored healthcare services category in the 2024 Best in KLAS Awards: Software & Services report. For employers and unions of all sizes who struggle with how to contain the ever-rising cost of providing healthcare for their teams, Marathon Health is a proven solution that delivers cost savings and better health outcomes.

Key Points: 
  • Marathon Health receives 2024 Best in KLAS award in the employer-sponsored healthcare services category.
  • This award marks the fourth time that Marathon Health has earned Best in KLAS (2024; 2023; 2021; 2020).
  • The company recently announced its merger with Everside Health, which was awarded 'Best in KLAS' in '22 and '19 (as legacy Activate Health).
  • We hear that Marathon Health is amazing, and we hear how much our people love Marathon Health."

USA Based CIPRA.ai Expands its Precision Chronic Care Services to India, Partners with RxDx, 2050 Healthcare, and ARTPARK @IISc Bangalore

Retrieved on: 
Thursday, February 15, 2024

SAN FRANCISCO, Feb. 15, 2024 /PRNewswire-PRWeb/ -- San Diego, California based leading health technology platform CIPRA.ai has announced the launch of its personalized services in India and a strategic partnership with renowned healthcare providers in the industry - RxDx and 2050 Healthcare and innovation partner ARTPARK @IISc Bangalore. The Bengaluru based RxDx, a NABH and NABL-accredited multispeciality healthcare chain, and 2050 Healthcare, a leading healthcare provider specializing in rehabilitation and home healthcare, will help CIPRA.ai expand its presence in India. ARTPARK @IISc Bangalore, a leading AI and robotics accelerator backed by the Indian Institute of Science, has become CIPRA.ai's innovation partner to help it scale growth objectives and achieve its first 10K patients by 2024. The primary goal of the partnership is to help address gaps in conventional care and capacitate patients and physicians to control and reverse chronic diseases using AI and data-driven precision care in India. Through collective efforts, CIPRA.ai also aims to become a health tool that enables healthcare providers to expand clinical capacities.

Key Points: 
  • CIPRA.ai has launched its health services in India to help patients combat chronic conditions through personalized and proactive care.
  • CIPRA.ai's subscription services are designed to offer precise and personalized patient care treating and reversing chronic conditions such as diabetes and hypertension.
  • Before launching services in India, CIPRA.ai has been successfully delivering hypertension and diabetes services in the USA since 2022.
  • CIPRA.ai plans to expand its focus beyond hypertension and diabetes to offer data-based precision care to more chronic diseases.

FDA Approves First Medication to Treat Severe Frostbite

Retrieved on: 
Wednesday, February 14, 2024

SILVER SPRING, Md., Feb. 14, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Aurlumyn (iloprost) injection to treat severe frostbite in adults to reduce the risk of finger or toe amputation.

Key Points: 
  • SILVER SPRING, Md., Feb. 14, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Aurlumyn (iloprost) injection to treat severe frostbite in adults to reduce the risk of finger or toe amputation.
  • Frostbite can occur in several stages, ranging from mild frostbite that does not require medical intervention and does not cause permanent skin damage, to severe frostbite when both the skin and underlying tissue are frozen and blood flow is stopped, sometimes requiring amputation.
  • Iloprost's efficacy in treating severe frostbite was primarily established in an open-label, controlled trial that randomized 47 adults with severe frostbite, who all received aspirin by vein and standard of care, into one of three treatment groups.
  • The two other groups received other medications that are unapproved for frostbite, given with iloprost (Group 2) or without iloprost (Group 3).

Sky Labs' CART BP Becomes the World's First to Complete Comparative Studies with All Blood Pressure Measurement Methods

Retrieved on: 
Wednesday, February 14, 2024

SEOUL, South Korea, Feb. 14, 2024 /PRNewswire/ -- CART BP is a ring-type 24/7 blood pressure monitor of the global healthcare startup Sky Labs(CEO Jack, Lee), and has fully established itself as the only ring-type wearable medical device to complete comparative studies with all blood pressure measurement methods, becoming the first in the world.  

Key Points: 
  • There are currently three main blood pressure measurement methods: auscultatory method in which a cuff-based blood pressure monitor and stethoscope are used in clinics to measure blood pressure; invasive blood pressure measurement method in which a needle or catheter is inserted into an artery (A-line) to measure intra-arterial pressure; and Ambulatory Blood Pressure Monitoring (ABPM) that measures blood pressure during a 24-hour period outside clinics by attaching a cuff and monitor to the body.
  • To prove CART BP's effectiveness, Sky Labs completed all comparative studies with these three blood pressure measurement methods.
  • In addition, Sky Labs validated accuracy in comparative studies with the invasive arterial blood pressure measurement method and standard stethoscopy.
  • CART BP is highly useful compared to other blood pressure monitors in that it enables 24-hour measurements of even blood pressure variability when an individual is asleep, not to mention awake.

Sky Labs' CART BP Becomes the World's First to Complete Comparative Studies with All Blood Pressure Measurement Methods

Retrieved on: 
Wednesday, February 14, 2024

SEOUL, South Korea, Feb. 14, 2024 /PRNewswire/ -- CART BP is a ring-type 24/7 blood pressure monitor of the global healthcare startup Sky Labs(CEO Jack, Lee), and has fully established itself as the only ring-type wearable medical device to complete comparative studies with all blood pressure measurement methods, becoming the first in the world.  

Key Points: 
  • There are currently three main blood pressure measurement methods: auscultatory method in which a cuff-based blood pressure monitor and stethoscope are used in clinics to measure blood pressure; invasive blood pressure measurement method in which a needle or catheter is inserted into an artery (A-line) to measure intra-arterial pressure; and Ambulatory Blood Pressure Monitoring (ABPM) that measures blood pressure during a 24-hour period outside clinics by attaching a cuff and monitor to the body.
  • To prove CART BP's effectiveness, Sky Labs completed all comparative studies with these three blood pressure measurement methods.
  • In addition, Sky Labs validated accuracy in comparative studies with the invasive arterial blood pressure measurement method and standard stethoscopy.
  • CART BP is highly useful compared to other blood pressure monitors in that it enables 24-hour measurements of even blood pressure variability when an individual is asleep, not to mention awake.

HIMALAYA TECHNOLOGIES ADDS FORTUNE 100 TELECOMMUNICATIONS EXECUTIVE TO ADVISORY BOARD; COMPANY TARGETING VAST TELEHEALTH MARKET

Retrieved on: 
Tuesday, February 13, 2024

Said Vik Grover, CEO: “I am thrilled Mr. Nahabedian has joined Himalaya to help us build a significantly larger organization.

Key Points: 
  • Said Vik Grover, CEO: “I am thrilled Mr. Nahabedian has joined Himalaya to help us build a significantly larger organization.
  • His vision, expertise, and network of contacts is a competitive advantage for our plans for the telehealth market.
  • With his help, Himalaya intends to capture meaningful share of the segment’s multi-billion dollar market.
  • I am very excited to bring HMLA into the telehealth market and create significant value for our shareholders.”